Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

7.840 +0.070 (+0.90%)
Streaming Delayed Price Updated: 9:37 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Bausch Health Shares Are Trading Higher Today ↗
 
Via Benzinga
News headline image
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
Via ACCESSWIRE
News headline image
Preview: Bausch Health Companies's Earnings ↗
 
Via Benzinga
News headline image
Salix Announces 2023 Gastrointestinal Health Scholars Program
Via ACCESSWIRE
News headline image
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
Via ACCESSWIRE
News headline image
'I Say, Move On': Cramer Prefers Nvidia Over This Cloud-Base Content Management Company Up 22% ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said L3Harris Technologies Inc (NYSE: LHX) is still a buy. 
Via Benzinga
News headline image
7 Retirement Stocks to Buy Now OR You’ll Be Kicking Yourself Later ↗
Consider adding these leading companies to a portfolio that is aimed at getting you to the finish line when it comes to retiring. 
Via InvestorPlace
Looking Into Bausch Health Companies's Return On Capital Employed ↗
 
Via Benzinga
Bausch Health Companies's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Bausch Health Posts Q3 Profit Despite Lower Sales, Trims FY22 Outlook ↗
 
Via Benzinga
News headline image
Recap: Bausch Health Companies Q3 Earnings ↗
Bausch Health Companies (NYSE:BHC) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Most Active Equity Options For Midday - Monday, Jan. 23 ↗
Here are the most active equity options for midday. 
Via Talk Markets
News headline image
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13 ↗
Benzinga Sam Bankman-Fried Arrested In The Bahamas 
Via Benzinga
News headline image
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits ↗
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO). 
Via Benzinga
News headline image
Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case
Via ACCESSWIRE
News headline image
Bausch Health Announces Third-Quarter 2022 Results
Via ACCESSWIRE
News headline image
Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference
Via ACCESSWIRE
News headline image
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250. 
Via Benzinga
News headline image
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge
Via ACCESSWIRE
News headline image
Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference
Via ACCESSWIRE
News headline image
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
Via ACCESSWIRE
News headline image
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. 
Via MarketBeat
News headline image
Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents
Via ACCESSWIRE
News headline image
The Profit and Protection Quantitative Stock-Picking System ↗
Should you try growth investing or value investing? What about momentum strategies? Use this system as the ultimate guide to stock picking. 
Via InvestorPlace
News headline image
Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022
Via ACCESSWIRE
News headline image
Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting
Via ACCESSWIRE
News headline image
Bausch Health to Announce Third Quarter 2022 Results on Nov. 3
Via ACCESSWIRE
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.